Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-08-06

FDA Approved: RISPERIDONE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves Sun Pharmaceutical's generic risperidone (ANDA) for the same indications as the brand-label. The approval covers schizophrenia, bipolar I disorder,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

ORIG AP for RISPERIDONE (RISPERIDONE)